Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04907812Phase 4Unknown
Phase 4, randomised, double-blind trial in edema comparing Tranexamic Acid (TXA) with Standard of Care (SOC) (2 arms). Primary endpoints: Adherence to protocol at 12 weeks, Treatment Completion Rate at 12 weeks and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04907812.